LB Pharmaceuticals Inc
Veridion Score
Composite trend over time
Why is LBRX moving today?
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for LBRX.
LBRX insider activity
LB Pharmaceuticals Inc
No multi-insider buying cluster in the last 90 days
Net buying: $85.0M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-10 | 2026-02-06 | KROIN DAVID | Insider | buy | $21.17 | 93,925 | 93,925 | $2.0M | SEC Form 4 |
| 2026-02-10 | 2026-02-06 | KROIN DAVID | Insider | buy | $21.17 | 378,444 | 378,444 | $8.0M | SEC Form 4 |
| 2025-09-16 | 2025-09-12 | Pontifax Management 4 G.P. (2015) Ltd. | Insider | buy | $15.00 | 1,000,000 | 1,411,681 | $15.0M | SEC Form 4 |
| 2025-09-16 | 2025-09-12 | Nussbaum Ran | Insider | buy | $15.00 | 1,000,000 | 1,411,681 | $15.0M | SEC Form 4 |
| 2025-09-16 | 2025-09-12 | KROIN DAVID | Insider | buy | $15.00 | 666,666 | 666,666 | $10.0M | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 3 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moLBRX contract awards, year to date.
Public federal awards linked to this ticker.
LBRX lobbying filings, year to date.
Registered lobbying filings matched to LB Pharmaceuticals Inc.